Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHYLTRANSFERASES AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2013/108126
Kind Code:
A3
Abstract:
The present invention relates to compositions and methods for biomarker screening and research. In particular, the present invention relates to VCP-KMT methyltransferases, antibodies to methylated VCP, and targets of VCP-KMT for screening and research applications.

Inventors:
FALNES PAL OYSTEIN (NO)
KERNSTOCK STEFAN (NO)
KLUNGLAND ARNE (NO)
FUSSER MARKUS (NO)
Application Number:
PCT/IB2013/000420
Publication Date:
December 27, 2013
Filing Date:
January 14, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV OSLO (NO)
UNIV OSLO HF (NO)
FALNES PAL OYSTEIN (NO)
KERNSTOCK STEFAN (NO)
KLUNGLAND ARNE (NO)
FUSSER MARKUS (NO)
International Classes:
C12Q1/48; A61K39/00; G01N33/574
Other References:
STEVEN G. GRAY: "Targeting Histone Deacetylases for the Treatment of Huntington's Disease", CNS NEUROSCIENCE & THERAPEUTICS, vol. 16, no. 6, 9 December 2010 (2010-12-09), pages 348 - 361, XP055068057, ISSN: 1755-5930, DOI: 10.1111/j.1755-5949.2010.00184.x
KLARA ACS ET AL: "The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks", NATURE STRUCTURAL & MOLECULAR BIOLOGY, vol. 18, no. 12, 27 November 2011 (2011-11-27), pages 1345 - 1350, XP055068064, ISSN: 1545-9993, DOI: 10.1038/nsmb.2188
PHILIPPE CLOUTIER ET AL: "A Newly Uncovered Group of Distantly Related Lysine Methyltransferases Preferentially Interact with Molecular Chaperones to Regulate Their Activity", PLOS GENETICS, vol. 9, no. 1, E1003210, 1 January 2013 (2013-01-01), pages 1 - 13, XP055068524, ISSN: 1553-7390, DOI: 10.1371/journal.pgen.1003210
KERNSTOCK STEFAN ET AL: "Lysine methylation of VCP by a member of a novel human protein methyltransferase family.", NATURE COMMUNICATIONS, vol. 3, 1038, 2012, XP002701165, ISSN: 2041-1723
NANDO DULAL DAS ET AL: "Sodium arsenite dependent protein expression analysis on human embryonic carcinoma (NCCIT) cell line", TOXICOLOGY LETTERS, vol. 207, no. 2, 2 September 2011 (2011-09-02), ELSEVIER BIOMEDICAL PRESS, AMSTERDAM, NL, pages 149 - 158, XP028312727, ISSN: 0378-4274, [retrieved on 20110908], DOI: 10.1016/J.TOXLET.2011.09.003
VIJ NEERAJ: "AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, vol. 12, no. 6A, December 2008 (2008-12-01), pages 2511 - 2518, XP002701166, ISSN: 1582-1838, DOI: 10.1111/j.1582-4934.2008.00462.x
BRAUN R J ET AL: "Mechanisms of Cdc48/VCP-mediated cell death - from yeast apoptosis to human disease", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH, vol. 1783, no. 7, 1 July 2008 (2008-07-01), ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, pages 1418 - 1435, XP022715887, ISSN: 0167-4889, [retrieved on 20080202], DOI: 10.1016/J.BBAMCR.2008.01.015
DOOLAN PADRAIG ET AL: "Microarray and Proteomics Expression Profiling Identifies Several Candidates, Including the Valosin-Containing Protein (VCP), Involved in Regulating High Cellular Growth Rate in Production CHO Cell Lines", BIOTECHNOLOGY AND BIOENGINEERING, vol. 106, no. 1, May 2010 (2010-05-01), pages 42 - 56, XP002701167, DOI: 10.1002/bit.22670
NALBANDIAN ANGELE ET AL: "The Homozygote VCPR155H/R155H Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology", PLOS ONE, vol. 7, no. 9, E46308, September 2012 (2012-09-01), pages 1 - 10, XP002701168
Download PDF: